第一代重熔高交联聚乙烯全髋关节置换术后15年CT骨溶解分析
本研究对84例患者105例初次全髋关节置换术进行至少15年随访,所有病例使用Longevity高交联聚乙烯内衬和26mm氧化锆股骨头。通过CT三维及多平面重建评估骨溶解,结果显示15年随访时髋臼或股骨均无明显骨溶解,无髋臼杯松动或内衬破裂。
要点
- 第一代重熔高交联聚乙烯内衬在15年随访中未增加骨溶解风险
- CT三维重建未发现髋臼或股骨骨溶解,无杯松动或内衬破裂
- 磨损颗粒的生物活性可能低于传统聚乙烯
核心结论
- 第一代重熔高交联聚乙烯内衬在至少15年随访中不增加骨溶解风险。
研究设计与样本
- 回顾性评估84例患者105例初次全髋关节置换术,平均随访15.9年(范围15-18年)。
- 所有病例使用Longevity高交联聚乙烯内衬和26mm氧化锆股骨头。
- 通过CT三维及多平面重建图像识别骨溶解区域。
主要发现
- 15年随访CT三维多平面重建图像显示所有患者髋臼和股骨均无明显骨溶解。
- 无患者出现髋臼杯松动或内衬破裂。
关键数值与推荐
- 平均随访15.9年(范围15-18年),105例全髋关节置换术。
- 使用Longevity高交联聚乙烯内衬和26mm氧化锆股骨头。
临床怎么用
- 第一代重熔高交联聚乙烯内衬在长期随访中未增加骨溶解风险,支持其临床使用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Low polyethylene wear rate and low incidence of osteolysis have been reported after total hip arthroplasty (THA) using first-generation remelted highly cross-linked polyethylene (HXLPE). However, osteolysis has not been evaluated in long-term studies of these patients (15 years or more). The present study assessed computed tomography (CT) images to determine the incidence of osteolysis associated with HXLPE in THA during at least 15 years of follow-up. METHODS: We evaluated 105 primary THAs in 84 patients (77 women and 7 men). Mean follow-up was 15.9 years (range, 15-18 years). All THAs used a Longevity HXLPE liner and a 26-mm zirconia femoral head. Areas of osteolysis were identified from CT images using 3D and multiplanar reconstruction views. RESULTS: CT 3D multiplanar reconstruction images at 15-year follow-up showed no obvious osteolysis in the acetabulum or femur of any patient. No patients developed cup loosening or liner breakage. CONCLUSION: Our study indicates that first-generation remelted HXLPE liners do not increase the risk of osteolysis during 15-year follow-up and suggests that the wear particles from first-generation remelted HXLPE are less biologically active than those generated by conventional polyethylene devices.
引用
- Fukui K, Kaneuji A, Wang X, et al. Computed Tomographic Osteolytic Analysis of a First-Generation Remelted Highly Cross-Linked Polyethylene in Total Hip Arthroplasty-At a Minimum of 15-Year Follow-Up. J Arthroplasty. 2019. PMID: 31948813. doi:10.1016/j.arth.2019.12.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。